PMC:7307149 / 7135-7563 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T49","span":{"begin":143,"end":146},"obj":"Body_part"},{"id":"T50","span":{"begin":299,"end":302},"obj":"Body_part"}],"attributes":[{"id":"A49","pred":"fma_id","subj":"T49","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A50","pred":"fma_id","subj":"T50","obj":"http://purl.org/sig/ont/fma/fma84795"}],"text":"t the fewest SARS-CoV peptides, in keeping with previous clinical data associating this allele with severe disease (49).\nFIG 1 Distribution of HLA allelic presentation of 8- to 12-mers from the SARS-CoV-2 proteome. At right, the number of peptides (see Table S1) that putatively bind to each of 145 HLA alleles is shown as a series of horizontal bars, with dark and light shading indicating the number of tightly (\u003c50 nM) and lo"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T51","span":{"begin":13,"end":21},"obj":"Disease"},{"id":"T52","span":{"begin":194,"end":202},"obj":"Disease"}],"attributes":[{"id":"A51","pred":"mondo_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A52","pred":"mondo_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"t the fewest SARS-CoV peptides, in keeping with previous clinical data associating this allele with severe disease (49).\nFIG 1 Distribution of HLA allelic presentation of 8- to 12-mers from the SARS-CoV-2 proteome. At right, the number of peptides (see Table S1) that putatively bind to each of 145 HLA alleles is shown as a series of horizontal bars, with dark and light shading indicating the number of tightly (\u003c50 nM) and lo"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T73","span":{"begin":22,"end":30},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T74","span":{"begin":239,"end":247},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T75","span":{"begin":259,"end":261},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T76","span":{"begin":323,"end":324},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"t the fewest SARS-CoV peptides, in keeping with previous clinical data associating this allele with severe disease (49).\nFIG 1 Distribution of HLA allelic presentation of 8- to 12-mers from the SARS-CoV-2 proteome. At right, the number of peptides (see Table S1) that putatively bind to each of 145 HLA alleles is shown as a series of horizontal bars, with dark and light shading indicating the number of tightly (\u003c50 nM) and lo"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T20","span":{"begin":22,"end":30},"obj":"Chemical"},{"id":"T21","span":{"begin":239,"end":247},"obj":"Chemical"}],"attributes":[{"id":"A20","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A21","pred":"chebi_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"}],"text":"t the fewest SARS-CoV peptides, in keeping with previous clinical data associating this allele with severe disease (49).\nFIG 1 Distribution of HLA allelic presentation of 8- to 12-mers from the SARS-CoV-2 proteome. At right, the number of peptides (see Table S1) that putatively bind to each of 145 HLA alleles is shown as a series of horizontal bars, with dark and light shading indicating the number of tightly (\u003c50 nM) and lo"}

{"project":"LitCovid-PubTator","denotations":[{"id":"162","span":{"begin":13,"end":21},"obj":"Species"},{"id":"167","span":{"begin":194,"end":204},"obj":"Species"}],"attributes":[{"id":"A162","pred":"tao:has_database_id","subj":"162","obj":"Tax:694009"},{"id":"A167","pred":"tao:has_database_id","subj":"167","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"t the fewest SARS-CoV peptides, in keeping with previous clinical data associating this allele with severe disease (49).\nFIG 1 Distribution of HLA allelic presentation of 8- to 12-mers from the SARS-CoV-2 proteome. At right, the number of peptides (see Table S1) that putatively bind to each of 145 HLA alleles is shown as a series of horizontal bars, with dark and light shading indicating the number of tightly (\u003c50 nM) and lo"}

{"project":"LitCovid-sentences","denotations":[{"id":"T49","span":{"begin":121,"end":214},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"t the fewest SARS-CoV peptides, in keeping with previous clinical data associating this allele with severe disease (49).\nFIG 1 Distribution of HLA allelic presentation of 8- to 12-mers from the SARS-CoV-2 proteome. At right, the number of peptides (see Table S1) that putatively bind to each of 145 HLA alleles is shown as a series of horizontal bars, with dark and light shading indicating the number of tightly (\u003c50 nM) and lo"}

{"project":"2_test","denotations":[{"id":"32303592-12969506-65501635","span":{"begin":116,"end":118},"obj":"12969506"}],"text":"t the fewest SARS-CoV peptides, in keeping with previous clinical data associating this allele with severe disease (49).\nFIG 1 Distribution of HLA allelic presentation of 8- to 12-mers from the SARS-CoV-2 proteome. At right, the number of peptides (see Table S1) that putatively bind to each of 145 HLA alleles is shown as a series of horizontal bars, with dark and light shading indicating the number of tightly (\u003c50 nM) and lo"}